Your cat was diagnosed with GI Lymphoma, Large Cell (High Grade). Second most common form of feline alimentary lymphoma after small cell. Aggressive behaviour with shorter survival times. Compare 7 treatment options for cats including COP Protocol, CHOP-Based Protocol (Modified Wisconsin), VAPC Protocol (Vinblastine-Based) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — GI Lymphoma, Large Cell (High Grade)
Feline Oncology Treatment Guide
GI Lymphoma, Large Cell (High Grade)
GI-localised or disseminated
Round Cell
About This Cancer
Large cell (high-grade) gastrointestinal lymphoma is a more aggressive form of intestinal cancer in cats. Unlike the small cell form, which infiltrates the intestinal lining gradually, large cell lymphoma often forms discrete masses or thickened segments of bowel and progresses more rapidly. It can arise from either T-cells or B-cells and tends to cause more dramatic symptoms including significant weight loss, poor appetite, vomiting, and sometimes abdominal masses that can be felt on examination. The prognosis is significantly more guarded than for small cell disease, with median survival typically in the range of two to nine months. Multi-drug chemotherapy protocols (similar to those used in dogs) can achieve remission in some cats, and those that respond well to initial treatment have the best outlook.
WHO Modified Staging for Feline Lymphoma
Same staging system as small cell, but histological grade is the primary prognostic determinant.
Prognostic Factors(3)
Minimum Workup(8 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.